Biotech

All Articles

Gene publisher Tome giving up 131 workers

.Only days after genetics publisher Volume Biosciences revealed confidential operational slices, a m...

Repare gives up 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is giving up a quarter of its own workforce as the oncology biotech downsize its precl...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken another step towards recognizing a profit on its own $6.5 billion ni...

Gain's phase 1 succeed paves way to show Parkinson's medicine's worth

.Gain Therapeutics has actually established its own direct proving the effectiveness of its Parkinso...

Actinogen records brand-new stage 2 information to salvage clinical depression medicine

.Actinogen Medical's hopes-- and supply price-- have recoiled somewhat coming from earlier this mont...

Pfizer and Front runner incorporate Quotient to multibillion-dollar formula

.Crown Jewel Pioneering and also Pfizer have actually added Quotient right into their 10-program par...

Bayer pens $547M contract to push borders of noncoding RNA

.Bayer executives were eager to stress and anxiety to Ferocious this summer months that the German p...

UK reveals plans to launch 18 brand new scientific trial centers

.In the middle of a yearslong medical test decline in the U.K., a brand new public-private collabora...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing strategies to shutter cancer cells immunology study system

.Adhering to the announcement of a sizable layoff round in April and a major rebuilding project intr...

Neurocrine's KarXT competitor attacks in phase 2-- but simply at low dosage

.Neurocrine Biosciences has obtained its own hoped-for profile page in a phase 2 mental illness tria...